Relationship between 1, 25-dihydroxyvitamin-d, calcium and uric acid in urinary stone formers

Urologia Internationalis

Volumn 56, Issue 1, 1996, Pages 16-20

  Jarrar, K ^a   Amasheh, R A ^a   Graef, V ^a   Weidner, W ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

1; 2 5 Dihydroxy vitamin D; Age; Calcium; Phosphate; Uric acid; Urinary stones

Indexed keywords

CALCITRIOL; CALCIUM; PHOSPHATE; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CALCIUM EXCRETION; CALCIUM STONE; CALCIUM URINE LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SERUM; URINALYSIS; URINE; UROLITHIASIS; VITAMIN BLOOD LEVEL;

EID: 0030027874     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000282801     Document Type: Article

References (18)

1. Hering FJ: Risiko der Hamstcinbildung: in Hautmann R, Lutzeycr W (eds): Harnsteinfibel, Köln-Lövenich, Deutscher Ärztcverlag, 1980. pp 18-19.
2. Lcskovar P, Hartung R, Sichert A, Wcllnhofer E: Unkorrigierte sowie osmolarität- und crcati-ninkorrigierte Konzentration des ionisierten und des Gcsamtcalciums im Harn rezidivierender Steinbildncr und gesunder Vergleichs-pcrsoncn, Urology [A] 1980;19:207-213.
3. May P, Sökcland J, Braun J: Harmstcinlciden, Stuttgart, Thieme, 1988.
4. Robertson WG, Paecock M: Pathogenesis of urolithiasis; in Schneider HJ (ed): Handbook of Urology, Urolithiasis: Etiology, Diagnosis, Berlin, Springer, 1985. vol 17/1. pp 185-334.
5. Gracf V, Schmidtmann H, Jarrar K: Verbesserung der enzymatischen Zitratbestimmung im Urin, Urologe [B] 1985;25:270-272.
6. Nichols Institute: Instructions for 1.25-Dihy-droxyvitamin-D Assay Kit, San Juan Capistrano, Nichols Institute, 1992.
7. Hollis BW: Assay of circulating 1.25-dihy-droxyvitamin-D involving a novel single-cartridge extraction and purification procedure, ClinChem 1986:32:2060-2063.
8. Reinhardt TA, Horst RL, Orf JW, Hollis BW: A microassay for 1.25-dihydroxyvitamin-D not requiring high performance liquid chromatography: Application to clinical studies, J Clin Endocrinol Mctab 1984:58:91-98.
9. Henry RJ: Clinical Chemistry, New York, Harper &Row, 1974.
10. Town MIL Gchm S, Hammer B, Ziegenhorn J: A sensitive colorimetric method for the enzymatic determination of uric acid, J Clin Chem ClinBiochem 1983:23:591.
11. Bartels H, Böhmer M, Heierli C: Serum Kreatininbestimmung ohne Enteiweissen, Clin Chim Acta 1972:37:193-197.
12. Grindlcr EM, King JD: Rapid colorimetric determination of calcium in biologic fluids with mcthylthymol blue, Am J Clin Pathol 1972.58: 376-382.
13. Hartwell D, Johanson JS, Christiansen C: Discrepancy between serum concentrations of 1.25-dihydroxyvitamin-D metabolites measured by radioimmunoassay and thymus radioreceptor assay during vitamin Di treatment, Scand J Clin Lab Invest 1989;49:545-553.
14. Hummer L, Christiansen C, Tjellsen L: Discrepancy between serum 1.25-dihydroxychole-calciferol measured by radioimmunoassay and cytosol radioreceptor assay, Scand J Clin Lab Invest 1985;45:725-733.
15. Oftcbro H, Falch JA, Holmberg I, Haug E: Validation of a radioreceptor assay for 1.25-dihy-droxyvitamin-D using selected ion monitoring GC-MS, Clin Chim Acta 1988;176:157-168.
16. Sherman SS, Hollis BW, Tobin JD: Vitamin-D status and related parameters in a healthy population: The effects of age, sex, and season, J Endocrinol Metab 1990:71:405-413.
17. Hering FJ: Physiologie und Pathophysiologie des Kalziumstoffwcchscls; in Hautmann R, Lutzeyer W (eds): Hamstcinfibel, Köln-Lövenich, Deutscher Ärzteverlag, 1980. pp 43-55.
18. Jarrar K, Boedecker RH: Langzeitbehandlung bei Calcium-Oxalatstein-Patienten mit Allopurinol, Thiaziden sowie Kombination beider Infstanzen bei 66 Patienten; in Gasser G, Vah-lensieck W (eds), Fortschritte der Urologie und Nephrologie, Pathogenese und Klinik der Harnsteine XL Darmstadt, Stcinkopff, 1985. vol 23. pp 400-405